Avanos Medical posted an 8.8% revenue increase to $182.2 million in Q1 2026, driven by strong growth in its Specialty Nutrition Systems segment. The company earned $0.11 per share diluted, with adjusted earnings per share at $0.22. On April 14, 2026, Avanos announced a definitive agreement to be acquired by American Industrial Partners affiliates for $1.272 billion in cash. Despite a slight decline in net income and cash flow, the acquisition signals confidence in Avanos' strategic direction and market position.
The global microneedle drug delivery systems market is projected to grow from $7.04 billion in 2025 to $14.37 billion by 2035, at a CAGR of 7.4%. Growth is fueled by rising demand for minimally invasive, pain-free, and self-administered drug delivery...
Nathan Allman, founder of Ondo Finance, has died unexpectedly, prompting a leadership change with longtime President Ian De Bode appointed as CEO. Ondo Finance is a leading player in tokenized real-world assets, with products linking crypto wallets t...
Bitcoin is trading in a narrow range around $76,500 with muted market activity as traders await the upcoming U.S. Personal Consumption Expenditures inflation report, a key factor for institutional demand. Despite recent macroeconomic shocks, bitcoin'...
Humanity's price surged 21.2% from $0.19 to a local high of $0.2519, driven by strong buying pressure and increased trading volume, especially on Binance. Buyers defended key support levels, pushing the net buying volume higher and sparking speculati...
Near Protocol (NEAR) surged 72% in one week, leading a broader altcoin rally marked by concentrated capital inflows and fragmented liquidity across crypto assets. This rally shows traders favoring assets with sustained momentum rather than short-live...
